Prior to 2023, the JMFC was required to personally visit the patient to ascertain the voluntariness of the Living Will and endorse it, adding a significant procedural hurdle and time delay. The 2023 amendments simplified this by removing the mandatory JMFC visit. Now, the hospital only needs to inform the JMFC before withdrawing treatment, ensuring transparency without the earlier procedural burden. This change is a common MCQ trap as students might recall the older, more stringent JMFC role.

The clarification was crucial because some interpretations considered CANH (artificial feeding and hydration via tubes) as basic care, not a medical treatment, and thus not eligible for withdrawal under passive euthanasia. The Harish Rana (2026) case, overturning a Delhi High Court decision, explicitly stated that CANH is a medical treatment. This means it can be withdrawn under the passive euthanasia framework if deemed futile, allowing patients in Persistent Vegetative State (PVS) to die with dignity even if not on mechanical life support. This distinction is vital for statement-based questions.

The 'Right to die with dignity' primarily addresses the problem of prolonged, undignified suffering and the artificial prolongation of life for individuals with irreversible, terminal illnesses or in a Persistent Vegetative State (PVS) with no hope of recovery. It grants individuals autonomy over their end-of-life decisions, preventing unnecessary pain, preserving their dignity, and alleviating the emotional and financial burden on families when medical interventions only serve to extend suffering, not life. No other provision directly addresses this specific aspect of individual autonomy at the end of life.

• •Prevents prolonged, undignified suffering.
• •Grants autonomy over end-of-life decisions.
• •Alleviates emotional and financial burden on families.
• •Ensures dignity when life is artificially prolonged without hope of recovery.

In the Harish Rana case, the family petitioned the Supreme Court after the Delhi High Court initially rejected their plea. The Supreme Court then constituted two medical boards (Primary and Secondary) as per guidelines. These boards thoroughly examined Harish Rana, who was in PVS since 2013, and certified that there was no hope of recovery. A key challenge was the initial High Court's view on CANH. The Supreme Court clarified that CANH is a medical treatment that could be withdrawn. Ultimately, with the medical boards' certification and SC's approval, life support (including CANH) was withdrawn.

The 'Right to die with dignity' explicitly does not cover active euthanasia (deliberately causing death), physician-assisted suicide, or requests for euthanasia based on mental health conditions, depression, or non-terminal illnesses. These exclusions are maintained primarily due to ethical concerns about the sanctity of life, the potential for misuse, and the belief that such actions constitute a criminal offense. The focus remains on allowing a natural death when life is artificially prolonged, not actively ending it.

• •Active euthanasia (deliberately causing death).
• •Physician-assisted suicide.
• •Requests based on mental health conditions or non-terminal illnesses.

Practical challenges include lack of awareness about Living Wills, difficulty in understanding complex medical terminology, ensuring proper attestation by two independent witnesses, and the need for endorsement by a Judicial Magistrate First Class (JMFC) (though simplified in 2023, informing JMFC is still required). Overcoming these requires public awareness campaigns, standardized, simplified templates for Living Wills, accessible legal aid for drafting, and clear guidelines for medical professionals on how to interpret and act upon them.

• •Lack of public awareness.
• •Complexity of medical and legal language.
• •Ensuring proper attestation by witnesses.
• •Navigating the JMFC notification process.

Critics primarily point to the multi-layered medical board approval process, the continued involvement of judicial authorities (even if simplified), and the potential for delays, especially in urgent cases. They also highlight the lack of awareness among both the public and medical practitioners. To make it more accessible while maintaining safeguards, reforms could include: Decentralization (empowering district-level medical authorities), Public Awareness (nationwide campaigns), Standardization (uniform, easy-to-understand Living Will formats), and Training (specialized training for doctors and legal professionals).

India's approach is significantly more conservative, strictly permitting only passive euthanasia under stringent judicial and medical oversight, rooted in the interpretation of Article 21 as a right to a dignified life, not an active right to end life. Countries like the Netherlands and Canada, however, have legalized active euthanasia or physician-assisted suicide under specific conditions (e.g., unbearable suffering, no reasonable alternative, informed consent). While India focuses on allowing natural death by withdrawing futile treatment, these countries allow direct intervention to end life. This reflects differing societal, ethical, and legal philosophies regarding the sanctity of life and individual autonomy.

A ruling in the 'All Creatures Great and Small' case could have significant implications. If the Supreme Court provides guidelines for dignified death in cases of extreme suffering from specific, incurable diseases like rabies, it might broaden the interpretation of 'dignified death' beyond just PVS or terminal illnesses where life is artificially prolonged. This could potentially lead to: expansion of scope (including specific conditions causing unbearable, irreversible suffering), disease-specific protocols (need for tailored guidelines), and ethical debate (intensifying the debate on 'unbearable suffering'). It could push the legal framework to address quality of life in severe, painful conditions more directly.

The current framework attempts to balance individual autonomy (through the Living Will provision) with the state's interest in preserving life (by strictly prohibiting active euthanasia and mandating multiple safeguards for passive euthanasia). When a Living Will is absent, the balance shifts more towards preservation of life, requiring the consent of family members or legal guardians, and crucially, the certification by two independent medical boards that the patient's condition is irreversible and there is no hope of recovery. This multi-layered approval process ensures that decisions are not arbitrary and are always in the patient's 'best interest', as determined by medical and familial consensus, under judicial oversight.

Prior to 2023, the JMFC was required to personally visit the patient to ascertain the voluntariness of the Living Will and endorse it, adding a significant procedural hurdle and time delay. The 2023 amendments simplified this by removing the mandatory JMFC visit. Now, the hospital only needs to inform the JMFC before withdrawing treatment, ensuring transparency without the earlier procedural burden. This change is a common MCQ trap as students might recall the older, more stringent JMFC role.

The clarification was crucial because some interpretations considered CANH (artificial feeding and hydration via tubes) as basic care, not a medical treatment, and thus not eligible for withdrawal under passive euthanasia. The Harish Rana (2026) case, overturning a Delhi High Court decision, explicitly stated that CANH is a medical treatment. This means it can be withdrawn under the passive euthanasia framework if deemed futile, allowing patients in Persistent Vegetative State (PVS) to die with dignity even if not on mechanical life support. This distinction is vital for statement-based questions.

The 'Right to die with dignity' primarily addresses the problem of prolonged, undignified suffering and the artificial prolongation of life for individuals with irreversible, terminal illnesses or in a Persistent Vegetative State (PVS) with no hope of recovery. It grants individuals autonomy over their end-of-life decisions, preventing unnecessary pain, preserving their dignity, and alleviating the emotional and financial burden on families when medical interventions only serve to extend suffering, not life. No other provision directly addresses this specific aspect of individual autonomy at the end of life.

• •Prevents prolonged, undignified suffering.
• •Grants autonomy over end-of-life decisions.
• •Alleviates emotional and financial burden on families.
• •Ensures dignity when life is artificially prolonged without hope of recovery.

In the Harish Rana case, the family petitioned the Supreme Court after the Delhi High Court initially rejected their plea. The Supreme Court then constituted two medical boards (Primary and Secondary) as per guidelines. These boards thoroughly examined Harish Rana, who was in PVS since 2013, and certified that there was no hope of recovery. A key challenge was the initial High Court's view on CANH. The Supreme Court clarified that CANH is a medical treatment that could be withdrawn. Ultimately, with the medical boards' certification and SC's approval, life support (including CANH) was withdrawn.

The 'Right to die with dignity' explicitly does not cover active euthanasia (deliberately causing death), physician-assisted suicide, or requests for euthanasia based on mental health conditions, depression, or non-terminal illnesses. These exclusions are maintained primarily due to ethical concerns about the sanctity of life, the potential for misuse, and the belief that such actions constitute a criminal offense. The focus remains on allowing a natural death when life is artificially prolonged, not actively ending it.

• •Active euthanasia (deliberately causing death).
• •Physician-assisted suicide.
• •Requests based on mental health conditions or non-terminal illnesses.

Practical challenges include lack of awareness about Living Wills, difficulty in understanding complex medical terminology, ensuring proper attestation by two independent witnesses, and the need for endorsement by a Judicial Magistrate First Class (JMFC) (though simplified in 2023, informing JMFC is still required). Overcoming these requires public awareness campaigns, standardized, simplified templates for Living Wills, accessible legal aid for drafting, and clear guidelines for medical professionals on how to interpret and act upon them.

• •Lack of public awareness.
• •Complexity of medical and legal language.
• •Ensuring proper attestation by witnesses.
• •Navigating the JMFC notification process.

Critics primarily point to the multi-layered medical board approval process, the continued involvement of judicial authorities (even if simplified), and the potential for delays, especially in urgent cases. They also highlight the lack of awareness among both the public and medical practitioners. To make it more accessible while maintaining safeguards, reforms could include: Decentralization (empowering district-level medical authorities), Public Awareness (nationwide campaigns), Standardization (uniform, easy-to-understand Living Will formats), and Training (specialized training for doctors and legal professionals).

India's approach is significantly more conservative, strictly permitting only passive euthanasia under stringent judicial and medical oversight, rooted in the interpretation of Article 21 as a right to a dignified life, not an active right to end life. Countries like the Netherlands and Canada, however, have legalized active euthanasia or physician-assisted suicide under specific conditions (e.g., unbearable suffering, no reasonable alternative, informed consent). While India focuses on allowing natural death by withdrawing futile treatment, these countries allow direct intervention to end life. This reflects differing societal, ethical, and legal philosophies regarding the sanctity of life and individual autonomy.

A ruling in the 'All Creatures Great and Small' case could have significant implications. If the Supreme Court provides guidelines for dignified death in cases of extreme suffering from specific, incurable diseases like rabies, it might broaden the interpretation of 'dignified death' beyond just PVS or terminal illnesses where life is artificially prolonged. This could potentially lead to: expansion of scope (including specific conditions causing unbearable, irreversible suffering), disease-specific protocols (need for tailored guidelines), and ethical debate (intensifying the debate on 'unbearable suffering'). It could push the legal framework to address quality of life in severe, painful conditions more directly.

The current framework attempts to balance individual autonomy (through the Living Will provision) with the state's interest in preserving life (by strictly prohibiting active euthanasia and mandating multiple safeguards for passive euthanasia). When a Living Will is absent, the balance shifts more towards preservation of life, requiring the consent of family members or legal guardians, and crucially, the certification by two independent medical boards that the patient's condition is irreversible and there is no hope of recovery. This multi-layered approval process ensures that decisions are not arbitrary and are always in the patient's 'best interest', as determined by medical and familial consensus, under judicial oversight.